Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cognitive Change | Behavioral: High-Demand Photography Behavioral: Moderate-Demand Photography Behavioral: At-Home Engagement | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 90 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Impact of Challenging Engagement on Cognition in Older Adults: A Clinical Trial |
Estimated Study Start Date : | June 1, 2019 |
Estimated Primary Completion Date : | February 2020 |
Estimated Study Completion Date : | February 2020 |
Arm | Intervention/treatment |
---|---|
Experimental: High-Demand Photography
A structured, high-demand photography course targeting 210 hours of engagement over 16 weeks.
|
Behavioral: High-Demand Photography
The high-demand photography group will receive 2.5 hours of instruction, twice a week, in a structured high-demand digital photography course plus 10 hours per week working on a special project at the research site without any formal instruction.
Other Name: Productive Engagement Group (High)
|
Active Comparator: Moderate-Demand Photography
A structured, moderate-demand photography course targeting 210 hours of engagement over 16 weeks.
|
Behavioral: Moderate-Demand Photography
The moderate-demand photography group will receive 2.5 hours of instruction, twice a week, in a structured moderate-demand digital photography course plus 10 hours per week working on a special project at the research site without any formal instruction.
Other Name: Productive Engagement Group (Moderate)
|
Placebo Comparator: At-Home Engagement Group
Participation, alone at home, in tasks that are relatively low in intellectual engagement.
|
Behavioral: At-Home Engagement
The placebo control group will engage, alone at home, in tasks that are relatively low in intellectual engagement such as listening to music and radio or completing work-books that rely primarily on activation of knowledge.
Other Name: Placebo Control
|
Cognitive function will be measured using an episodic memory composite score. This score is composed of three tasks that measure episodic memory: National Institutes of Health (NIH) Picture Sequence Memory Test, Woodcock-Johnson Memory for names, and Rey Auditory Verbal Learning Test. See secondary outcomes 11-13 for more information on each measure.
A normalized distribution of the dependent variables from these measures will be created by applying a rank-ordered Blom transformation to pretest and posttest scores. The transformed scores will then be averaged to create the episodic memory composite score. Cronbach's alpha will be calculated to test the internal reliability of the episodic memory construct. These measurements will be taken at baseline, and then following the intervention.
Ages Eligible for Study: | 60 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Avanti Dey, PhD | 972-883-3734 | axd170006@utdallas.edu | |
Contact: Hector Gonzalez, BS | 972-883-3733 | andyg@utdallas.edu |
United States, Texas | |
The engAGE Center: A Community Based Engagement Environment | Recruiting |
Irving, Texas, United States, 75039 | |
Contact: Hector Gonzalez |
Principal Investigator: | Denise Park, PhD | University of Texas at Dallas |
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date ICMJE | May 22, 2019 | ||||
First Posted Date ICMJE | May 24, 2019 | ||||
Last Update Posted Date | May 24, 2019 | ||||
Estimated Study Start Date ICMJE | June 1, 2019 | ||||
Estimated Primary Completion Date | February 2020 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE |
|
||||
Original Primary Outcome Measures ICMJE | Same as current | ||||
Change History | No Changes Posted | ||||
Current Secondary Outcome Measures ICMJE |
|
||||
Original Secondary Outcome Measures ICMJE | Same as current | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title ICMJE | Impact of Challenging Engagement on Cognition in Older Adults | ||||
Official Title ICMJE | Impact of Challenging Engagement on Cognition in Older Adults: A Clinical Trial | ||||
Brief Summary | The study will enroll 90 participants in the "Impact of Challenging Engagement" study and assign them to one of three groups: high-demand photography, moderate-demand photography, and active placebo. These initial groups will allow us to collect data and address the feasibility of converting the project into a full trial. Participants will participate in one of three different engagement conditions for 15 hours per week, based on successful results from the initial Active Interventions for the Aging Mind (AIM) study - approved by University of Texas Southwestern (UTSW) Institutional Review Board (IRB) #072010-144. In the Impact of Challenging Engagement study, the lab will expand on the results of the AIM study to determine if high-demand activities result in any observable brain changes when compared to moderate demand or placebo activities. Behavioral and neural measures of cognitive change will be assessed, providing considerable insight into mechanisms of change. Participants will be characterized thoroughly in terms of behavioral tests of cognitive function, and a subset of subjects who meet neuroimaging criteria will undergo a functional magnetic resonance imaging (fMRI) procedure. | ||||
Detailed Description |
All older adults experience some degree of cognitive compromise as they age and approximately 32 percent of adults aged 85 and older suffer from Alzheimer's disease (AD). The Alzheimer's Association estimates that delaying the onset of AD symptoms by only five years would reduce the rate of incidence by 50 percent! The present clinical trial builds on a wealth of observational work and more recent experimental research conducted in the PI's lab, which suggests that an important element of maintaining cognitive vitality for life is sustained engagement in mentally-challenging activities. In a U.S. sample of cognitively normal adults, we recently demonstrated that older adults who were randomly assigned to learn digital photography, quilting, or both, in fast-paced, demanding classes for 15 hours per week for three months, showed enhanced episodic memory function-both at the end of the engagement period and, importantly, one year later (Park et al., 2014). The observed memory improvements were in comparison to two active control conditions that were low in new learning: a social engagement group that had fun but did not engage in active learning, and a placebo condition where participants worked on low-effort cognitive tasks that relied on use of previous knowledge. We also found similar facilitation effects when older adults were trained to use many different applications on an iPad. The lab most recently reported that older participants who participated in high-effort engagement conditions showed an increase in neural efficiency, exhibiting a change in neural activity from a pre-intervention pattern characteristic of older adults to a post-intervention pattern typical of young adults. Based on these findings, which included relatively small numbers of subjects, we will conduct a larger clinical trial to determine whether mentally challenging activities facilitate memory in cognitively normal adults via changes of neural structure and function. We propose to conduct a clinical trial study that will (a) evaluate the efficacy of different types of engagement in improving cognitive function in older adults, (b) examine the likelihood that mental effort invested is the underlying mechanism accounting for engagement effects, (c) show whether engaging in high-demand activities results in reliable brain changes. We expect to demonstrate that when older adults engage for a sustained period of time in high-effort tasks (learning photography), both their memory and the modulation capacity of their brain will increase. Randomization Procedure and Statistical Analyses: Potential participants will complete an initial eligibility form. We will contact those who are deemed eligible, and we will follow up with a TICS cognitive phone interview screening and provide the link to an on-line demographic enrollment questionnaire. We will invite subjects who pass these screens to attend an informational session. At these sessions, project RAs will consent potential participants and have them complete the MRI screening form. We will schedule consenting participants for cognitive testing and MRI scans (if applicable). During the 3-week period set aside for cognitive and MRI testing, we will assign subjects among the three treatment arms using a centrally created randomization scheme. Because baseline data for all potential participants will be available at the time of randomization, we will use the rerandomization method of Morgan and Rubin (2012 Annals of Statistics 40:1263), which can achieve improved covariate balance in this setting. We will generate a series of randomizations and evaluate them for balance on age, education, and sex, designating balance in terms of the MANOVA F statistic comparing the distributions of the covariates across the treatment groups. Once we identify a randomization that meets this criterion, we will apply it to the eligible participants. Preliminary Analyses. In initial analyses, we will summarize categorical variables by proportions and continuous variables by means and quantiles. We will graph continuous variables and assess them for skewness, transforming if necessary (for example by logs or square roots) to render them more nearly normally distributed. We will explore relationships among variables by examining scatter plots and correlation matrices. We will conduct all analyses in R (version 3.3.2 or later) or SAS (version 9.4 or later). Analysis of Primary Outcome Variables. The primary cognitive outcome endpoint will be a composite, scalar episodic memory score. This measure will exhibit substantial between-subject variability, in that subjects who give high scores at baseline are likely to give high scores at follow-up as well. To account for this, in primary analyses we will adjust for baseline levels by analysis of covariance - i.e., including baseline values together with treatment arm in a regression model for the post-treatment outcome. Alternatively (and equivalently), we can analyze the outcome variable in a mixed model, evaluating a treatment effect by estimating a time-by-treatment interaction, including pre-treatment (baseline) and end-of-treatment (14-week) outcome. As a secondary analysis to further elucidate the magnitude and timing of treatment effects, we will seek to create parsimonious models of this outcome as a function of time, treatment arm, stratification factors (age, sex, education) and potentially other factors measured at baseline. The primary brain outcome will be a vector measure of fMRI activation in the four brain regions of interest: mid-cingulate, precuneus, intraparietal suclus, and inferior temporal gyrus. This measure is also likely to exhibit substantial between-subject variability. We will again analyze the outcome variable in a mixed model, evaluating the treatment effect by estimating a time-by-treatment interaction, and conduct a secondary analysis where we model activation in the four regions as functions of time, treatment arm, stratification factors (age, sex, education) and potentially other factors measured at baseline. |
||||
Study Type ICMJE | Interventional | ||||
Study Phase ICMJE | Not Applicable | ||||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Prevention |
||||
Condition ICMJE | Cognitive Change | ||||
Intervention ICMJE |
|
||||
Study Arms ICMJE |
|
||||
Publications * |
|
||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Unknown status | ||||
Estimated Enrollment ICMJE |
90 | ||||
Original Estimated Enrollment ICMJE | Same as current | ||||
Estimated Study Completion Date ICMJE | February 2020 | ||||
Estimated Primary Completion Date | February 2020 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE |
Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender ICMJE |
|
||||
Ages ICMJE | 60 Years and older (Adult, Older Adult) | ||||
Accepts Healthy Volunteers ICMJE | Yes | ||||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries ICMJE | United States | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number ICMJE | NCT03962439 | ||||
Other Study ID Numbers ICMJE | STU 072018-048 1R56AG058253-01 ( U.S. NIH Grant/Contract ) |
||||
Has Data Monitoring Committee | Not Provided | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement ICMJE | Not Provided | ||||
Responsible Party | The University of Texas at Dallas | ||||
Study Sponsor ICMJE | The University of Texas at Dallas | ||||
Collaborators ICMJE |
|
||||
Investigators ICMJE |
|
||||
PRS Account | The University of Texas at Dallas | ||||
Verification Date | May 2019 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |